Company Quick10K Filing
Acquired Sales
10-Q 2021-03-31 Filed 2021-05-17
10-K 2020-12-31 Filed 2021-03-31
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-19
10-Q 2020-03-31 Filed 2020-05-20
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-15
S-1 2019-08-02 Public Filing
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-13
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-10-05
10-Q 2018-03-31 Filed 2018-10-03
10-K 2017-12-31 Filed 2018-09-26
10-Q 2017-09-30 Filed 2018-09-19
10-Q 2017-06-30 Filed 2018-09-19
10-Q 2017-03-31 Filed 2018-09-18
10-K 2016-12-31 Filed 2018-09-06
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-28
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-04-01
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-17
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-13
10-Q 2012-03-31 Filed 2012-05-21
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-K 2010-09-30 Filed 2010-12-20
10-Q 2010-06-30 Filed 2010-08-23
10-Q 2010-03-31 Filed 2010-05-18
10-Q 2009-12-31 Filed 2010-02-16
8-K 2021-01-05
8-K 2020-12-18
8-K 2020-10-12
8-K 2020-09-09
8-K 2020-04-21
8-K 2020-02-24
8-K 2020-01-07
8-K 2019-11-14
8-K 2019-08-15
8-K 2019-07-29
8-K 2019-06-21
8-K 2019-05-23
8-K 2019-05-08
8-K 2019-04-30
8-K 2019-02-12
8-K 2018-11-18
8-K 2018-06-29

Acquired Sales Financials

AQSP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1875022172094271,3701,281678588374217842814101000000002,7974,3414,359
Accounts Receivable615885752382922300
Inventory
PP&E575256402,31454
Assets7172191,2501,0118631,0991,9531,5351,4271,3701,2811,3051,2341,040994845314101000000002,7976,2396,556
Accounts Payable42940133241634613794192151265825485213192953105929510210410610911211011321227
Long-Term Debt4544664714800031
Liabilities3,6713,1163,3383,4344,172395202169415126582548521319295710914916919221022824826729733918086104
Stockholders' Equity-2,954-2,897-2,088-2,423-3,3097041,7511,3661,3861,3191,2551,2471,2099929427233-16-56-109-148-169-192-210-228-248-267-297-3392,6176,1536,451
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue184059591,643140
Cost of Revenue0192316483104
Gross Profit1821364321936
R&D
SG&A6962,0021,008745748281757210460239745338494053-6317161616171717264562
Tax010000100000000
Net Income-694-1,809-525-4793,7421,046-38570-67253-8-5,182-217-50-870-38-49-40-53-20-23-18-18-20-91-35-44-897-146
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-17-50331-133-28577-51-37-89-0-165-214-62-92-32-39-17-04-1-0000-162-185-141
Cash Investing-921-03,6700-863001,0000-60275-40-2525000000-300
Cash Financing9246040-2,2520-30-20000-42,9593,625459